Huanghou Zhixie dropping pills alleviate ulcerative colitis via MAPK/ NF-kB signalling pathway

Huanghou Zhixie dropping pills alleviated colitis by modulating inflammatory factors through the Mitogen Activated Protein Kinase/Nuclear Factor kappa-light-chain-enhancer of activated B cells (MAPK/NF-κB) signalling pathway. The Huanghou Zhixie dropping pills could be a potential therapeutic option for ulcerative colitis treatment, offering a novel approach to managing the disease by targeting specific inflammatory pathways.